Biogeneric Pharma S A Ebgpis An Egyptian International Biopharmaceutical Company Focused On Developingmanufacturingand Commercializing Therapeutic Recombinant Proteinsantibodiesvaccinesand Biosimilarsestablished With Multinational Shareholdersbgp Operates A Modern Facility In 10Th Of Ramadan Industrial Cityegyptand Serves Markets In Emeafda Regulated Regionsafricaand The Middle East The Company Emphasizes Research And Development In Biosimilarstherapeutic Proteinsand Preventive Vaccinesits Manufacturing Capabilities Include Advanced Bioreactors And Chromatography Systemssupported By A Robust Quality Control Systembgp Is Involved In The Who Mrna Technology Transfer Programme To Develop Mrna Based Vaccines And Collaborates With Regional Distributors To Enhance Market Reachcommitted To Quality And Compliancebgp Adheres To International Regulatory Standardsensuring Product Safety And Sustainability
